Literature DB >> 2720904

Hepatocarcinogenic heterocyclic aromatic amines that induce cytochrome P-448 isozymes, mainly cytochrome P-448H (P-450IA2), responsible for mutagenic activation of the carcinogens in rat liver.

M Degawa1, S Tanimura, T Agatsuma, Y Hashimoto.   

Abstract

Male F344 rats were treated with hepatocarcinogenic heterocyclic aromatic amines such as amino acid- and protein-pyrolysate components (Trp P-1, Trp P-2, Glu P-1, Glu P-2, A alpha C, MeA alpha C, IQ and MeIQx) and changes in microsomal cytochrome P-450 isozymes in the livers were examined by means of immuno-Western blotting using anti-rat cytochrome P-450 monoclonal antibodies. The results suggested that all chemicals tested induce cytochrome P-448 isozymes, particularly cytochrome P-448H (P-450IA2), which efficiently mediate mutagenic activation of the carcinogens. This was substantiated by the enzymatic analyses with the substrates showing different characters to rat cytochrome P-450 isozyme-mediated mutagenesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2720904     DOI: 10.1093/carcin/10.6.1119

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

Review 1.  Using biomarkers of genetic susceptibility to enhance the study of cancer etiology.

Authors:  N Rothman; R B Hayes
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

2.  The impact of type I diabetes on rat liver gamma-glutamyltranspeptidase.

Authors:  S J Hemmings; R D Pekush
Journal:  Mol Cell Biochem       Date:  1994-10-26       Impact factor: 3.396

3.  Neonatal androgenization exacerbates alcohol-induced liver injury in adult rats, an effect abrogated by estrogen.

Authors:  Whitney M Ellefson; Ashley M Lakner; Alicia Hamilton; Iain H McKillop; Herbert L Bonkovsky; Nury M Steuerwald; Yvette M Huet; Laura W Schrum
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

4.  Enhancement by cigarette smoke exposure of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis in close association with elevation of hepatic CYP1A2.

Authors:  Akiyoshi Nishikawa; Fumio Furukawa; Makoto Miyauchi; Hwa-Young Son; Kazushi Okazaki; Akihiro Koide; Yukio Mori; Masao Hirose
Journal:  Jpn J Cancer Res       Date:  2002-01

5.  DNA adducts formed by 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat liver: dose-response on chronic administration.

Authors:  K Yamashita; M Adachi; S Kato; H Nakagama; M Ochiai; K Wakabayashi; S Sato; M Nagao; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1990-05

6.  Species difference among experimental rodents in the activity and induction of cytochrome P-450 isozymes for mutagenic activation of carcinogenic aromatic amines.

Authors:  M Degawa; T Agatsuma; Y Hashimoto
Journal:  Jpn J Cancer Res       Date:  1990-12

7.  Decreased levels of 2-amino-3-methylimidazo[4,5-f]quinoline-DNA adducts in rats treated with beta-carotene, alpha-tocopherol and freeze-dried aloe.

Authors:  N Uehara; Y Iwahori; M Asamoto; H Baba-Toriyama; M Iigo; M Ochiai; M Nagao; M Nakayama; M Degawa; K Matsumoto; I Hirono; H Beppu; K Fujita; H Tsuda
Journal:  Jpn J Cancer Res       Date:  1996-04

8.  Species difference among experimental rodents in induction of P450IA family enzymes by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Authors:  M Degawa; K Kobayashi; S Miura; H Arai; H Esumi; T Sugimura; Y Hashimoto
Journal:  Jpn J Cancer Res       Date:  1992-10

9.  Altered expression of hepatic CYP1A enzymes in rat hepatocarcinogenesis.

Authors:  M Degawa; S Miura; K Yoshinari; Y Hashimoto
Journal:  Jpn J Cancer Res       Date:  1995-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.